Source comparison
Best KPV Dosage for Skin Conditions: Dosing Comparison
Generalized atopic dermatitis Subcutaneous injection 500mcg–1mg Once daily Systemic MC1R sites in keratinocytes, dermal fibroblasts Best for diffuse inflammation. Systemic delivery ensures consistent receptor occupancy across all affected skin areas Localized
This comparison does not assign a generated winner or score.
- Generalized atopic dermatitis
- Subcutaneous injection
- 500mcg–1mg
- Once daily
- Systemic MC1R sites in keratinocytes, dermal fibroblasts
- Best for diffuse inflammation. Systemic delivery ensures consistent receptor occupancy across all affected skin areas
- Localized psoriasis plaques
- Topical cream (1–2% concentration)
- 1–2% w/w
- Twice daily
- Plaque keratinocytes, local inflammatory cells
- Higher local concentration than subcutaneous dosing achieves. Minimizes systemic exposure while maximizing plaque penetration
- Post-laser inflammation
- Topical cream (1% concentration)
- 1% w/w
- Twice daily for 7–14 days
- Treated dermal layers, melanocytes
- Prevents post-inflammatory hyperpigmentation by blocking NF-κB-driven melanocyte activation immediately after tissue injury
- Chronic inflammatory dermatosis (systemic)
- 1mg
- Systemic distribution to all MC1R-expressing tissues
- Appropriate when skin involvement is part of broader autoimmune process. Addresses dermal inflammation alongside systemic immune dysregulation